Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myelodysplastic Syndromes 22Leukemia 21Lymphoma, Non-Hodgkin 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Recurrence 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma 5Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Hematologic Neoplasms 3Graft vs Host Disease 3Burkitt Lymphoma 3Neoplasms 2Neoplasm, Residual 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Bone Marrow Failure Disorders 2

Interventions

fludarabine phosphate 5fludarabine 3Busulfan 3Antilymphocyte Serum 3Whole-Body Irradiation 2Mycophenolic Acid 2Cyclophosphamide 2Clofarabine 2Alemtuzumab 2treosulfan 1thymoglobulin 1eltrombopag 1X-Rays 1Thiotepa 1Therapeutics 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Emapalumab 1Cyclosporins 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Bone Marrow Failure Disorders × Clofarabine × Clear all
NCT04644016 2026-03-13

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
31 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡